Glial growth factor 2 treatment alleviates ischemia and reperfusion-damaged integrity of the blood-brain barrier through decreasing Mfsd2a/caveolin-1-mediated transcellular and Pdlim5/YAP/TAZ-mediated paracellular permeability-Reference-Cited by-同舟云学术

Glial growth factor 2 treatment alleviates ischemia and reperfusion-damaged integrity of the blood-brain barrier through decreasing Mfsd2a/caveolin-1-mediated transcellular and Pdlim5/YAP/TAZ-mediated paracellular permeability

Published:2024-06-20 Issue: Volume: Page:
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Zhang Xiao-ling,Du Wei-hong,Qian Shu-xia,Lu Xu-dong,Yu Xin,Fang Hai-lun,Dong Jia-li,Song Min,Sun Yan-yun,Wu Xiao-qiang,Shen Yu-fei,Hao Ya-nan,Shen Min-hui,Zhou Bei-qun,Wang Yan-ping,Xu Cong-ying,Jin Xin-chun

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41401-024-01323-7.pdf

Reference54 articles.

1. Desilles JP, Rouchaud A, Labreuche J, Meseguer E, Laissy JP, Serfaty JM, et al. Blood-brain barrier disruption is associated with increased mortality after endovascular therapy. Neurology. 2013;80:844–51.

2. Ridder DA, Wenzel J, Müller K, Töllner K, Tong XK, Assmann JC, et al. Brain endothelial TAK1 and NEMO safeguard the neurovascular unit. J Exp Med. 2015;212:1529–49.

3. Won S, Sayeed I, Peterson BL, Wali B, Kahn JS, Stein DG. Vitamin D prevents hypoxia/reoxygenation-induced blood-brain barrier disruption via vitamin D receptor-mediated NF-kappaB signaling pathways. PLoS One. 2015;10:e0122821.

4. Chen B, Friedman B, Cheng Q, Tsai P, Schim E, Kleinfeld D, et al. Severe blood-brain barrier disruption and surrounding tissue injury. Stroke. 2009;40:e666–74.

5. Wang YP, Du WH, Hu XY, Yu X, Guo C, Jin XC, et al. Targeting the blood-brain barrier to delay aging-accompanied neurological diseases by modulating gut microbiota, circadian rhythms, and their interplays. Acta Pharmaceutica Sin B. 2023;13:4667–87.